Lymph node dissection during radical cystectomy for bladder cancer: A two‐center comparative study of robotic versus open surgery

Author:

Sasaki Yutaro1ORCID,Daizumoto Kei1,Fukuta Kyotaro2,Shiozaki Keito2,Nishiyama Mitsuki1,Utsunomiya Seiya2,Kobayashi Saki1,Seto Kosuke2,Ueno Yoshiteru1,Tomida Ryotaro1ORCID,Kusuhara Yoshito1,Fukawa Tomoya1,Nakanishi Ryoichi2,Yamaguchi Kunihisa1,Yamamoto Yasuyo1,Izaki Hirofumi2,Takahashi Masayuki1ORCID

Affiliation:

1. Department of Urology Tokushima University Graduate School of Biomedical Sciences Tokushima Japan

2. Department of Urology Tokushima Prefectural Central Hospital Tokushima Japan

Abstract

AbstractIntroductionThis study was performed to evaluate the safety and efficacy of lymph node dissection (LND) during robot‐assisted radical cystectomy (RARC) compared with open radical cystectomy (ORC).MethodsFrom October 2003 to December 2021, 122 patients underwent LND during RARC and 103 patients underwent LND during ORC at Tokushima University Hospital and Tokushima Prefectural Central Hospital. We investigated the safety and efficacy of LND during RARC by comparing the surgical and oncological outcomes between the two groups.ResultsThe patients were significantly older in the RARC than the ORC group. The operative time was significantly shorter and the estimated blood loss was significantly lower in the RARC than the ORC group. Although the lymph node yield was significantly higher in the RARC than the ORC group, there was no significant difference in lymph node positivity between the groups. There was no significant difference in the incidence of local recurrence or distant metastasis between the two groups. The 5‐year survival rates (overall survival, cancer‐specific survival, and recurrence‐free survival) were not different between the RARC and ORC groups.ConclusionThis study suggests that the surgical and oncological safety and efficacy of LND during RARC are greater than those of LND during ORC. We believe that LND during RARC is a higher‐quality procedure than LND during ORC.

Publisher

Wiley

Subject

General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3